Content
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
Article By:
The Tokenist
Read
Wednesday, April 17, 2024 9:30 AM EDT
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.
In this article: ABT
UnitedHealth Group Beats Q1 Expectations, Revenues Surge To $99.8 Billion
Article By:
The Tokenist
Read
Tuesday, April 16, 2024 7:25 AM EDT
UnitedHealth Group has reported strong first quarter 2024 results, with revenues reaching $99.8 billion.
In this article: UNH
Marijuana Stocks Followed The Leader Last Week Tumbling 12%, On Average
Article By:
Lorimer Wilson
Read
Sunday, April 14, 2024 6:20 PM EDT
The bad news from Tilray (its Q3 net loss increased by 128%} took a toll last week on the constituents of both the Canadian Cannabis LPs Index and the American Cannabis MSOs Index with all 12 declining by an average of 12%.
Viking Therapeutics: Strong Results In Obesity
Article By:
MoneyShow.com
Read
Saturday, April 13, 2024 5:17 PM EDT
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100 billion market for weight loss drugs.
3 Buy Rated Stocks To Consider As Earnings Approach
Article By:
Zacks Investment Research
Read
Saturday, April 13, 2024 2:20 AM EDT
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.
Low Beta Tech Stocks To Consider For A Rebound Amid Heightened Market Volatility
Article By:
Zacks Investment Research
Read
Friday, April 12, 2024 10:20 PM EDT
With market volatility heating up investors will surely be looking for opportunities in the tech sector. After all, the Nasdaq is still up +7% year to date and has soared +32% over the last year despite dipping -1% so far this month.
Abbott Laboratories Dividend Stock Analysis
Article By:
Dividends4Life
Read
Friday, April 12, 2024 7:00 AM EDT
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the United States.
In this article: ABT
Current Analysis: Sonic Healthcare Limited
Article By:
Fredrik Arnold
Read
Thursday, April 11, 2024 9:45 PM EDT
Sonic Healthcare is a global pathology provider. Over the past year, Sonic’s share price fell 20.2% from $23.78 to $18.97 as of Thursday’s market close.
In this article: SKHCF
Current Analysis: Pfizer (PFE)
Article By:
Fredrik Arnold
Read
Wednesday, April 10, 2024 8:15 PM EDT
Pfizer (PFE) is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer’s share price fell 36.6% from $41.50 to $26.31 as of Wednesday’s market close.
Tilray's Q3 Financials Disappoint: Stock Declines 31%
Article By:
Lorimer Wilson
Read
Wednesday, April 10, 2024 6:46 PM EDT
Tilray's stock price is down 30.9% from its high last week as a result of the release of its disappointing Q3 financial results yesterday.
In this article: TLRY